Not Enough Patients for Clinical Trials

Not Enough Patients for Clinical Trials

With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps unprecedented in medical research. There are too many experimental cancer drugs in too many clinical trials, and not enough patients to test them on. Click here.


要查看或添加评论,请登录

Paul Lee的更多文章

社区洞察

其他会员也浏览了